1110014J01Rik Inhibitors
Chemical inhibitors of 1110014J01Rik operate through various molecular mechanisms to modulate the activity of this specific protein. Staurosporine serves as a broad-spectrum kinase inhibitor, targeting multiple kinases that are responsible for the phosphorylation of 1110014J01Rik, thus leading to the inhibition of its activity. Bisindolylmaleimide I, with a more focused approach, inhibits Protein Kinase C (PKC), which is known to phosphorylate and control the function of a plethora of proteins including 1110014J01Rik. Similarly, Genistein acts by obstructing the action of tyrosine kinases, which, if involved in the activation of 1110014J01Rik through phosphorylation, can lead to the inhibition of this protein.
Further expanding the arsenal of inhibitors, LY294002 and Wortmannin target the phosphoinositide 3-kinases (PI3K) pathway. By inhibiting PI3K, these chemicals prevent the activation of downstream signaling pathways such as Akt, which may be crucial for the phosphorylation and subsequent activity of 1110014J01Rik. PD98059 and U0126 both inhibit MEK, which is part of the MAPK/ERK pathway, a pathway that can be essential for the phosphorylation and activation of 1110014J01Rik. Preventing MEK from acting can thus inhibit the functional output of 1110014J01Rik. The chemical SB203580 specifically inhibits p38 MAP kinase, and SP600125 inhibits c-Jun N-terminal kinase (JNK), both of which might be responsible for the phosphorylation and regulation of 1110014J01Rik. Rapamycin targets the mammalian target of rapamycin (mTOR), a kinase that may play a role in the activation of 1110014J01Rik. Lastly, ZM-447439 and Dasatinib target Aurora kinases and Src family kinases respectively, which, if involved in the regulation of 1110014J01Rik, their inhibition would result in decreased activity of the protein.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent kinase inhibitor that can inhibit a broad range of kinases involved in various signaling pathways. It inhibits the protein 1110014J01Rik by targeting kinases that directly phosphorylate this protein, leading to a loss of its phosphorylation-dependent functions. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I, also known as GF109203X, is a specific inhibitor of Protein Kinase C (PKC). It inhibits 1110014J01Rik by inhibiting PKC, which is responsible for the phosphorylation and subsequent activation of multiple downstream proteins, including 1110014J01Rik, thereby preventing its functional activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can inhibit the phosphorylation of proteins by tyrosine kinases. By inhibiting these kinases, Genistein can prevent the activation of 1110014J01Rik if its activity is contingent upon tyrosine phosphorylation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of phosphoinositide 3-kinases (PI3K). By inhibiting PI3K, LY294002 can hinder the PI3K/Akt signaling pathway, which may be crucial for the activation and function of 1110014J01Rik, leading to its inhibition. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective inhibitor of mitogen-activated protein kinase kinase (MEK), which is part of the MAPK/ERK pathway. By inhibiting MEK, PD98059 can prevent the activation of ERK, which may be necessary for the functional activity of 1110014J01Rik, thus inhibiting the protein. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is another MEK inhibitor that prevents the activation of the MAPK/ERK pathway. By inhibiting MEK, U0126 can suppress the ERK activity that may be essential for the phosphorylation and activation of 1110014J01Rik, thereby inhibiting its function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAP kinase. By inhibiting p38, SB203580 can inhibit the downstream signaling that may be required for the activation or stabilization of 1110014J01Rik, leading to its functional inhibition. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK). It inhibits 1110014J01Rik by inhibiting JNK, which may phosphorylate and activate this protein, thereby preventing its functional activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a covalent inhibitor of PI3K. It inhibits 1110014J01Rik by blocking the PI3K/Akt pathway, potentially preventing the phosphorylation and activation of this protein, thus leading to its functional inhibition. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an inhibitor of the mammalian target of rapamycin (mTOR). It inhibits 1110014J01Rik by inhibiting mTOR, which may be involved in the phosphorylation and activation of 1110014J01Rik, thus preventing its functional activity. | ||||||